Wenjian Min

State Key Laboratory Of Natural Medicines And Jiangsu Provincial Key Laboratory Of Targetome And Innovative Drugs Medicines
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability.

Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability.

Journal: Journal of medicinal chemistry

Published: March 09, 2026

Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma.

Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma.

Journal: Journal of medicinal chemistry

Published: February 04, 2026

A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell Death.

A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell Death.

Journal: Journal of medicinal chemistry

Published: January 02, 2026

Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmias.

Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmias.

Journal: European heart journal

Published: December 18, 2025

Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance.

Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance.

Journal: Journal of medicinal chemistry

Published: December 09, 2025

Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy.

Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy.

Journal: Journal of medicinal chemistry

Published: November 17, 2025

Klotho-derived peptide 1 ameliorates hepatic fibrosis induced by αKlotho deficiency and liver injury.

Klotho-derived peptide 1 ameliorates hepatic fibrosis induced by αKlotho deficiency and liver injury.

Journal: International journal of biological sciences

Published: July 21, 2025

Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer.

Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: July 09, 2025

Fibrillin-1 is a novel ligand of the epidermal growth factor receptor promoting mesangial cell activation and glomerulosclerosis.

Fibrillin-1 is a novel ligand of the epidermal growth factor receptor promoting mesangial cell activation and glomerulosclerosis.

Journal: Kidney international

Published: June 18, 2025

Discovery of a Novel and Potent MET Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC.

Discovery of a Novel and Potent MET Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC.

Journal: Journal of medicinal chemistry

Published: June 03, 2025

From concept to application: Exploring the evolution and potential of DUBTAC technology.

From concept to application: Exploring the evolution and potential of DUBTAC technology.

Journal: Acta pharmaceutica Sinica. B

Published: May 23, 2025

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling Pathway.

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 14, 2025

Showing 1-12 of 45

Last Updated: 09/26/2026